SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001517022-24-000035
Filing Date
2024-04-23
Accepted
2024-04-23 08:32:33
Documents
1
Period of Report
2024-04-17
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K akba-20242304xkreosdrawdown.htm 8-K 26638
  Complete submission text file 0001517022-24-000035.txt   27788
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 24862777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)